Effect of new legislation in Germany on prevalence and harm of synthetic cannabinoids. (3rd October 2022)
- Record Type:
- Journal Article
- Title:
- Effect of new legislation in Germany on prevalence and harm of synthetic cannabinoids. (3rd October 2022)
- Main Title:
- Effect of new legislation in Germany on prevalence and harm of synthetic cannabinoids
- Authors:
- Sommer, Michaela J.
Halter, Sebastian
Angerer, Verena
Auwärter, Volker
Eyer, Florian
Liebetrau, Gesine
Ebbecke, Martin
Hermanns-Clausen, Maren - Abstract:
- Abstract: Context: New psychoactive substances (NPS) have become an ongoing threat to public health. To prevent the emergence and spread of NPS, a new German law, the 'NpSG' took effect in November 2016. This study presents an overview of analytically confirmed synthetic cannabinoid (SC) intoxications from January 2015 to December 2018. In order to demonstrate effects of the NpSG, the results of 23 month before and 25 month after the introduction of the law were compared. Methods: Within the scope of a prospective observational study blood and urine samples were collected from emergency patients with suspected NPS intoxication. Comprehensive drug analyses were performed by LC-MS/MS analysis. Results: In the period considered, 138 patients were included. Within these, SC intake was verified in 65 patients (73%) in the period before the law change, and in 30 patients (61%) after. The median age increased significantly from 19.5 to 26 years. Seizures and admission to the ICU were reported significantly less frequently (seizures 29% versus 6.7%, p = 0.0283; ICU admission 42% versus 13%, p = 0.0089). 34 different SCs were detected, including four SCs (Cumyl-PEGACLONE, 5 F-MDMB-P7AICA, EG-018, 5 F-Cumyl-P7AICA) not covered by the NpSG at the time of detection. In the first period the most prevalent SC was MDMB-CHMICA ( n = 24). 5 F-ADB was the most prevalent SC overall, detected in 7 patients (11%) in the first, and in 24 patients (80%) in the second period. Conclusion: TheAbstract: Context: New psychoactive substances (NPS) have become an ongoing threat to public health. To prevent the emergence and spread of NPS, a new German law, the 'NpSG' took effect in November 2016. This study presents an overview of analytically confirmed synthetic cannabinoid (SC) intoxications from January 2015 to December 2018. In order to demonstrate effects of the NpSG, the results of 23 month before and 25 month after the introduction of the law were compared. Methods: Within the scope of a prospective observational study blood and urine samples were collected from emergency patients with suspected NPS intoxication. Comprehensive drug analyses were performed by LC-MS/MS analysis. Results: In the period considered, 138 patients were included. Within these, SC intake was verified in 65 patients (73%) in the period before the law change, and in 30 patients (61%) after. The median age increased significantly from 19.5 to 26 years. Seizures and admission to the ICU were reported significantly less frequently (seizures 29% versus 6.7%, p = 0.0283; ICU admission 42% versus 13%, p = 0.0089). 34 different SCs were detected, including four SCs (Cumyl-PEGACLONE, 5 F-MDMB-P7AICA, EG-018, 5 F-Cumyl-P7AICA) not covered by the NpSG at the time of detection. In the first period the most prevalent SC was MDMB-CHMICA ( n = 24). 5 F-ADB was the most prevalent SC overall, detected in 7 patients (11%) in the first, and in 24 patients (80%) in the second period. Conclusion: The number of SC intoxications decreased overall after the implementation of the NpSG. The shift in the detected SCs can be considered a direct effect of the NpSG but unfortunately the market supply does not appear to have been reduced. Although changes in the age distribution and in the severity of intoxications may be seen as secondary effects of the law, the main objectives of the new law to prevent the emergence and spread of further chemical variations of known scheduled drugs, have apparently not been achieved from the perspective of this study. … (more)
- Is Part Of:
- Clinical toxicology. Volume 60:Number 10(2022)
- Journal:
- Clinical toxicology
- Issue:
- Volume 60:Number 10(2022)
- Issue Display:
- Volume 60, Issue 10 (2022)
- Year:
- 2022
- Volume:
- 60
- Issue:
- 10
- Issue Sort Value:
- 2022-0060-0010-0000
- Page Start:
- 1130
- Page End:
- 1138
- Publication Date:
- 2022-10-03
- Subjects:
- Intoxication -- synthetic cannabinoids -- NPS -- NpSG
Toxicology -- Periodicals
Toxicological emergencies -- Periodicals
615.9 - Journal URLs:
- http://informahealthcare.com/loi/ctx ↗
http://informahealthcare.com ↗ - DOI:
- 10.1080/15563650.2022.2095282 ↗
- Languages:
- English
- ISSNs:
- 1556-3650
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3286.399550
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 24243.xml